Yellow fever: A decade of reemergence

JAMA

Volumn 276, Issue 14, 1996, Pages 1157-1162

  Robertson, Susan E ^a   Hull, Barbara P ^a   Tomori, Oyewale ^b   Bele, Okwo ^b   LeDuc, James W ^a   Esteves, Karin ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b WHO REGIONAL OFFICE FOR AFRICA   (Congo)

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

AEDES AEGYPTI; AFRICA; ARTICLE; FOREST WORKER; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION CONTROL; INFECTION RISK; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; SOUTH AMERICA; TRAVEL; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

EID: 0029758956     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.14.1157     Document Type: Article

References (62)

1. World Health Organization. Yellow fever in 1992 and 1993. Wkly Epidemiol Rec. 1995;70:65-70.
2. World Health Organization. Yellow fever virus surveillance in Western Africa. Wkly Epidemiol Rec. 1994;69:93-95.
3. World Health Organization. Yellow fever, Ghana. Wkly Epidemiol Rec. 1994;69:44, 76, 243, 260.
4. World Health Organization. Yellow fever outbreak in Liberia: update. Wkly Epidemiol Rec. 1995; 70:360.
5. World Health Organization. Yellow fever: investigation of an epidemic in Imo State, Nigeria. Wkly Epidemiol Rec. 1995;70:107-110.
6. World Health Organization. Yellow fever in Sierra Leone. Wkly Epidemiol Rec. 1995;70:367.
7. World Health Organization. Yellow fever, Gabon. Wkly Epidemiol Rec. 1995;70:163-164.
8. World Health Organization. Yellow fever, Kenya. Wkly Epidemiol Rec. 1995;70:175-176.
9. World Health Organization. Yellow fever, Kenya. Wkly Epidemiol Rec. 1996;71:103.
10. World Health Organization. Yellow fever, Peru. Wkly Epidemiol Rec. 1995;70:235.
11. Smith HH. Controlling yellow fever. In: Strode GK, ed. yellow Fever. New York, NY: McGraw Hill Book Co Inc; 1951:543-628.
12. Nasidi A, Monath TP, DeCock K, et al. Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg. 1989;83:401-406.
13. Monath TP. Yellow fever: victor, victoria? conqueror, conquest? epidemics and research in the last forty years and prospects for the future. Am J Trop Med Hyg. 1991;45:1-43.
14. Division of Epidemiological Surveillance and Health Situation and Trend Assessment. Global Health Situation and Projections: Estimates. Geneva, Switzerland: World Health Organization; 1992. Document WHO/HST/92.1.
15. Expanded Programme on Immunization. EPI Information System: Global Summary. Geneva, Switzerland: World Health Organization; 1996. Document WHO/EPI/CEIS/96.07.
16. World Health Organization. Prevention and Control of Yellow Fever in Africa. Geneva, Switzerland: World Health Organization; 1986.
17. LeDuc JW. World Health Organization strategy for emerging infectious diseases. JAMA. 1996; 275:318-320.
18. Monath T. Yellow fever, a medically neglected disease: report on a seminar. Rev Infect Dis. 1987; 9:165-175.
19. World Health Organization. Yellow fever, Kenya. Wkly Epidemiol Rec. 1993;68:159-160.
20. Okello BGA, Agata N, Ounia J, et al. Outbreak of yellow fever in Kenya. Lancet. 1993;341:489.
21. World Health Organization. Yellow fever vaccinations near one million mark in Liberia. Geneva, Switzerland: World Health Organization; February 9, 1996. Press release WHO/9.
22. Pan American Health Organization. Isolation of dengue type 3 virus prompts concern and action. Bull Pan Am Health Organ. 1995;29:184-185.
23. World Health Organization. Dengue in the Americas: update. Wkly Epidemiol Rec. 1995;70: 333-334.
24. Bres PLJ. A century of progress in combating yellow fever. Bull World Health Organ. 1986;64: 775-786.
25. Lederberg J, Shope RE, Oakes SC Jr, eds, for the Institute of Medicine. Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press; 1992.
26. Expanded Programme on Immunization in the African Region. Field Guide for District Level Staff on Priority Communicable Disease Surveillance. Brazzaville, Congo: World Health Organization Regional Office for Africa; 1994.
27. Expanded Programme on Immunization, Programme for Acute Respiratory Infections, Global Blood Safety Initiative, UNICEF. Product Information Sheets, 1993-1994. 10th ed. Geneva, Switzerland: World Health Organization and United Nations Children's Fund; 1993. Document WHO/ UNICEF/EPI.TS/93.1.
28. Tagliante-Saracino J, Dagnan-N'cho S, Ekra- Kouadio D. Côntrole sanitaires aux frontières: cas de la Côte d'Ivoire. In: Proceedings of the 4th International Seminar on Immunization in Africa; March 13-16, 1994; Yamoussoukro, Ivory Coast. Lyon, France: Fondation Marcel Mérieux;1994:224- 228.
29. World Health Organization. International Health Regulations (1969), Amended in 1973 and 1981. 3rd annotated ed. Geneva, Switzerland: World Health Organization; 1983.
30. World Health Organization. Yellow fever vaccinating centres for international travel: amendments to 1991 publication. Wkly Epidemiol Rec. 1996;71:69.
31. Groot H, Ribeiro RB. Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine. Bull World Health Organ. 1962;27:699-707.
32. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ. 1981; 56:895-900.
33. Gateff C, Relyveld EH, Le Gonidec G, et al. Etude d'une nouvelle association vaccinale quintuple. Ann Microbiol (Paris). 1973;124B:387-409.
34. Ruben FL, Smith EA, Foster SO, et al. Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children. Bull World Health Organ. 1973;48:175-181.
35. Yvonnet B, Courgeaget P, Deubel V, Diop-Mar I, Digoutte JP, Chiron JP. Simultaneous administration of hepatitis B and yellow fever vaccines. J Med Virol. 1985;19:307-311.
36. Receveur M-C, Quiniou J-M, Delprat P, Monlun E, Lehner V, Le Bras M. Vaccination simultanée contre l'hépatite A et la fièvre jaune. Bull Soc Pathol Exot. 1993;86:406-409.
37. Ambrosch F, Fritzell B, Gregor J, et al. Combined vaccination against yellow fever and typhoid fever: a comparative trial. Vaccine. 1994;12:625-628.
38. Robertson SE. Yellow Fever: The Immunological Basis for Immunization. Geneva, Switzerland: World Health Organization; 1993. Document WHO/EPI/GEN/93.18.
39. Goujon C, Touir M, Feuillie V, Coulaud P, Dupont B, Sansonetti P. Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus (abstract). J Travel Med. 1995;2:145.
40. World Health Organization. International Travel and Health: Vaccination Requirements and Health Advice: Situation as on 1 January 1996. Geneva, Switzerland: World Health Organization; 1996.
41. Nasidi A, Monath TP, Vandenberg J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg. 1993;87:337-339.
42. Tsai TF, Paul R, Lynberg MC, Letson GW. Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis. 1993;168: 1520-1523.
43. Centers for Disease Control and Prevention. Health Information for International Travel 1995. Atlanta, Georgia: US Dept of Health and Human Services, Public Health Service; August 1995. Health and Human Services publication 95-8280.
44. Department of Health Welsh Office, Scottish Office Home and Health Department, Department of Health and Social Security (Northern Ireland), Public Health Laboratory Service. Health Information for Overseas Travel, 1995 Edition. London, England: Her Majesty's Stationery Office; 1995.
45. World Health Organization. Yellow Fever Vaccinating Centres for International Travel. Geneva, Switzerland: World Health Organization; 1991.
46. Fisch A, Prazuck T, Hugon-Coly F, Clerel M, Hornez T, Lafaix C. Couverture vaccinale des voyageurs au départ de Paris vers l'Afrique. In: Proceedings of the 4th International Seminar on Immunizations in Africa; March 13-16, 1996; Yamoussouicro, Ivory Coast. Lyon, France: Fondation Marcel Mérieux;1994:205-209.
47. Monath TP, Craven RB, Adjukiewicz A, et al. Yellow fever in The Gambia, 1978-1979: epidemiologic aspects with observations on the occurrence of Orungo virus infections. Am J Trop Med Hyg. 1980;29:912-928.
48. World Health Organization. Yellow fever in 1979. Wkly Epidemiol Rec. 1980;55:345-351.
49. Expanded Programme on Immunization. Inclusion of yellow fever vaccine in the EPI, Gambia. Wkly Epidemiol Rec. 1996;71:181-185.
50. Tikasingh ES, ed. Studies on the Natural History of Yellow Fever in Trinidad. Port of Spain, Trinidad and Tobago: Caribbean Epidemiology Centre, Pan American Health Organization/World Health Organization; 1991.
51. Rawlins SC, Hull B, Chadee DD, et al. Sylvatic yellow fever activity in Trinidad, 1988-1989. Trans R Soc Trop Med Hyg. 1990;84:142-143.
52. Department for Economic and Social Information and Policy Analysis, Population Division. World Population Prospects, 1994 Revision. New York, NY: United Nations; 1994.
53. Yellow fever in 1987. Wkly Epidemiol Rec. 1989; 64:37-43.
54. Vincens R, Robert V, Pignon D, Zeller H, Ghipponi PM, Digoutte JP. L' épidémie de fièvre jaune de l'Extrême Nord du Cameroun en 1990: premier isolement du virus amaril au Cameroun. Bull World Health Urgan. 1990;71:173-176.
55. Yellow fever in 1982. Wkly Epidemiol Rec. 1983; 58:313-317.
56. Addy PAK, Minami K, Agadzi VK. Recent yellow fever epidemics in Ghana (1969-1983). East Afr Mea J. June 1986:422-434.
57. Chambon L, Wone I, Bres P, et al. Une épidémie de fièvre jaune au Sénégal en 1965: L' épidémie humaine. Bull World Health Organ. 1967;36: 113-150.
58. Meegan JM. Yellow Fever Vaccine. Geneva, Switzerland: World Health Organization; 1991. Document WHO/EPI/GEN/91.6.
59. Tomori O, Nasidi A, Mung K. Status of yellow fever vaccination in the Expanded Programme on immunization (EPI), In: Proceedings of the 4th International Seminar on Immunization in Africa; March 13-16, 1994; Yamoussoukro, Ivory Coast. Lyon, France: Fondation Marcel Mérieux;1994:107- 112.
60. The World Bank. World Development Report 1993: Investing in Health. Oxford, England: Oxford University Press; 1993.
61. Robertson RL, Hall AJ, Crivelli PE, Lowe Y, Inskip HM, Snow SK. Cost-effectiveness of immunizations: The Gambia revisited. Health Pol Plan. 1992;7:111-122.
62. Monath TP, Nasidi A. Should yellow fever vaccine be included in the Expanded Program of Immunization in Africa? a cost-effectiveness analysis for Nigeria Am J Trop Med Hyg. 1993;48:274-299.